Influence of perioperative sHLA I concentrations on the histological development of the liver graft

Transplant International

Volumn 13, Issue SUPPL. 1, 2000, Pages

  Muller J ^a   Schenk, M ^a   Zipfel, A ^a   Lauchart, W ^a   Viebahn, R ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Flush catheter; Liver transplantation; Rejection; Soluble HLAI (sHLA)

Indexed keywords

HLA ANTIGEN CLASS 1;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHOLESTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOLOGY; INCIDENCE; INTRAOPERATIVE PERIOD; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NECROSIS; PATHOLOGY; POSTOPERATIVE COMPLICATION; REPERFUSION; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; AGED; CHOLESTASIS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INCIDENCE; INTRAOPERATIVE PERIOD; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NECROSIS; POSTOPERATIVE COMPLICATIONS; REPERFUSION;

EID: 0005380027     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2000.tb02080.x     Document Type: Article

References (12)

1. DeVito Haynes LD, Jankowska Gan E, Heisey DM, Cornwell RD, Meyer KC, Love RB, Burlingham WJ (1997) Soluble HLA class I in epithelial lining fluid of lung transplants: associations with graft outcome. Hum Immunol 52: 95-108
2. Filaci G, Contini P, Brenci S, Lanza L, Scudeletti M, Indiveri F, Puppo F (1995) Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation. Tissue Antigens 46: 117-123
3. Hagihara M, Shimura T, Takebe K, Munkhbat B, Hosoi K, Kagawa T, Watanabe N, Matsuzaki S, Yamamoto K, Sato K, Tsuji K (1997) Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders. J Gastroenterol 32: 338-343
4. Mathew JM, Shenoy S, Phelan D, Lowell J, Howard T, Mohanakumar T (1996) Biochemical and immunological evaluation of donor-specific soluble HLA in the circulation of liver transplant recipients. Transplantation 62: 217-223
5. Puppo F, Scudeletti M, Indiveri F, Ferrone S (1995) Serum HLA class I antigens: markers and modulators of an immune response? Immunol Today 16: 124-127
6. Rhynes VK, McDonald JC, Gelder FB, Aultman DF, Hayes JM, McMillan RW, Mancini MC (1993) Soluble HLA class I in the serum of transplant recipients. Ann Surg 217: 485-489
7. Satoh S, Thomson AW, Nakamura K, Warty V, Todo S (1995) Circulating ICAM-1, E-selectin, IL-2 receptor, and HLA class I in human small bowel, liver, and small bowel-plus-liver transplant recipients. Transplantation 60: 558-562
8. Tilg H, Westhoff U, Vogel W, Aulitzky WE, Herold M, Margreiter R, Huber C, Grosse-Wilde H (1992) Soluble HLA class I serum concentrations increase with transplant-related complications after liver transplantation. J Hepatol 14: 417-419
9. Van Rood JJ, Leeuwen A van, Santen MCT van (1970) Anti HL-A2 inhibitor in normal human serum. Nature 226: 366-367
10. Zavazava N, Müller-Ruchholtz W (1994) Quantitative and biochemical characterization of soluble HLA class I antigens shed by cultured human cells. Hum Immunol 40: 174-178
11. Zavazava N, Leimenstoll G, Müller-Ruchholtz W (1990) Measurement of soluble MHC class I molecules in renal graft patients: a noninvasive allograft monitor. J Clin Lab Anal 4: 426-429
12. Zavazava N, Bottcher H, Müller-Ruchholtz W (1993) Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigen 42: 20-26